Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: APVMA (Australian Pesticides and Veterinary Medicines Authority)
EQUINE ROTAVIRUS (INACTIVATED); APRAMYCIN; AMPHOTERICIN B; NEOMYCIN; THIOMERSAL
ZOETIS AUSTRALIA PTY LTD
vaccine - rotavirus (killed)
MISC. VACCINES OR ANTI SERA
EQUINE ROTAVIRUS (INACTIVATED) BIOLOGICAL Active 1.0 RP; APRAMYCIN ANTIBIOTIC Other 0.0 P; AMPHOTERICIN B ANTIBIOTIC Other 0.0 P; NEOMYCIN ANTIBIOTIC Other 0.0 P; THIOMERSAL MERCURY Other 0.1 %
10ml; 10x10mL
VM - Veterinary Medicine
ZOETIS AUSTRALIA
HORSE PREGNANT
IMMUNOTHERAPY
ROTAVIRUS ENTERITIS | VACCINE | EQUINE ROTAVIRUS
Poison schedule: 0; Withholding period: WHP: NIL; Host/pest details: HORSE PREGNANT: [ROTAVIRUS ENTERITIS, VACCINE]; Poison schedule: 0; Withholding period: ; Host/pest details: HORSE PREGNANT: [ROTAVIRUS ENTERITIS, VACCINE]; For the vaccination of pregnant mares to stimulate production of antibodies against equine rotavirus in colostrum and milk as an aid in the management of rotavirus enteritis.See PRECAUTIONS and SIDE EFFECTS on label.
Registered
2023-07-01
' • • • APPENDIX 2 AUSTRALIAN GOVERNMENT AUSTRALIAN PESTICIDES AND VETERINARY MEDICINES AUTHORITY TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPS) (VETERINARY PRODUCTS) Select appropriate: D New Product (include all applicable RLPs) OR 0 Variation (highlight instructions that are being varied). Approval no. of label being varied: 56501/0607. Signal heading: Product name: Active constituenVs: Statement of claims: Net contents: DIRECTIONS FOR USE Heading: Restraints: CONTRA INDICATIONS: PRECAUTIONS: Side effects: Dosage & ADMINISTRATION: FOR ANIMAL TREATMENT ONLY DUVAXYN® R EQUINE ROTAVIRUS VACCINE (INACTIVATED) Contains equine rotavirus (RP 2: 1.0), grown in tissue culture, chemically inactivated and added to an oil adjuvant. Contains Polymyxin B, neomycin, Amphotericin Band thiomersal (0.01%) as preservatives. For the vaccination of pregnant mares to stimulate the production of antibodies against equine rotavirus in colostrum and milk as an aid in the management of rotavirus enteritis. A~ 10mL vial "'If 10 x 10mL vials RLP DIRECTIONS FOR USE Approveu READ ENCLOSED LEAFLET BEFORE USING THIS PRODUCT READ INSTRUCTIONS ON BACK OF LABEL BEFORE USING THIS PRODUCT N/A N/A For use in pregnant mares only. Foals born from vaccinated mares may still show signs of diarrhoea. Thorough diagnosis of the infectious agents, including rotavirus, is recommended to assist in the control of infectious diarrhoea. Allergic reactions such as anaphylaxis occur rarely and may require parenteral treatment with an antihistamine, a corticosteroid or adrenalin as appropriate. Use entire contents immediately upon opening. Administer 1 mL intramuscularly in the 8th, gth and 10 1 h months of pregnancy using aseptic technique. A booster dose should be given one month prior to foaling for each subsequent pregnancy. The presence of antibodies to rotavirus, even at high levels, is not always sufficient to prevent rotaviral disease in foals. Management practices should be implemented in conjunction with vaccination to assist in reducing the impa Διαβάστε το πλήρες έγγραφο
PRODUCT NAME: DUVAXYN® R EQUINE ROTAVIRUS VACCINE (INACTIVATED) PAGE: 1 OF 6 THIS VERSION ISSUED: 6 JUNE 2014 SAFETY DATA SHEET Issued by: Zoetis Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA SECTION 1 - IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND SUPPLIER ZOETIS AUSTRALIA PTY LTD ABN 94 156 476 425 Level 6, 5 Rider Blvd Rhodes NSW 2138 AUSTRALIA Tel: 1800 814 883 Fax: (02) 8876 0444 Email: australia.animalhealth@zoetis.com PRODUCT IDENTIFIER: DUVAXYN® R EQUINE ROTAVIRUS VACCINE (INACTIVATED) APVMA APPROVAL NO: 56501 OTHER NAMES: None. CHEMICAL FAMILY: Contains chemically inactivated equine rotavirus in an oily adjuvant. Also contains preservatives. RECOMMENDED USE: For the vaccination of pregnant mares to stimulate the production of antibodies against equine rotavirus in colostrum and milk as an aid in the management of rotavirus enteritis. RESTRICTIONS ON USE For veterinary use only. EMERGENCY PHONE: 1800 814 883 (ALL HOURS) SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S36, S24/25. Wear suitable protective clothing. Avoid contact with skin and eyes. ADG CLASSIFICATION: None allocated. Not a Dangerous Good according to Australian Dangerous Goods (ADG) Code, IATA or IMSBC criteria. GHS CLASSIFICATION: GHS LABEL ELEMENTS: NONE. NOT HAZARDOUS. SIGNAL WORD: NONE. NOT HAZARDOUS. HAZARD STATEMENT: NONE. NOT HAZARDOUS. PREVENTION P102: Keep out of reach of children. P235: Keep cool, preferably between 2 and 8°C, but do not freeze. P262: Do not get in eyes, on skin, or on clothing. P281: Use personal protective equipment as required. RESPONSE P353: Rinse skin or shower with water. P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P370+P378: Not combustible. Use extinguishing media suited to burni Διαβάστε το πλήρες έγγραφο